In 2020 Nang Kuang and Frenius Kabi entered into an exclusive agreement for commercializing Oleovit® Oral Vitamin D3 Drops for the treatment of Vitamin D deficiency in infants, children and adults. Frenius Kabi is among TOP500 pharmaceutical companies in the world… Continue reading
Nang Kuang and Austrian pharmaceutical company Cyathus Exquirere entered into an exclusive agreement for MAH rights of an inhalation product in 2019. Cyathus Exquirere is a pharmaceutical company incorporated in the year 2000 in Vienna, Austria… Continue reading
Nang Kuang and Molteni Farmaceutici (Molteni) have signed an exclusive agreement in August 2020 for the commercialization of pain management therapy in Mainland China for post-operative care of cancer patients. Molteni is a leading pharmaceutical company in Europe founded in 1892. It is a specialty leader in the opioid drug market researching and developing solutions … Continue reading
Nang Kuang and Pharma-Zentrale GmbH (Zentrale) have signed an exclusive agreement for the commercialization of an orally administered biological product in Mainland China for the treatment of diarrhea in infants, children and adults. Zentrale is a German century-old company specialized in probiotic- and phyto-pharmaceuticals, biological APIs as well as contract manufacturing… Continue reading
BEIJING Apr. 30, 2024—- Nang Kuang and the Spanish pharmaceutical company Ferrer Internacional, S.A. (Ferrer) have signed an agreement for the exclusive distribution of ERTACZO® (sertaconazole nitrate cream) in Mainland China and Hong Kong SAR. Sertaconazole nitrate is a new broad-spectrum imidazole antifungal agent. ERTACZO® is indicated for the topical treatment of interdigital tinea pedis … Continue reading
In January 2023, Nang Kuang has entered into a long-term exclusive licensing partnership with biosyn Arzneimittel GmbH（biosyn）for the commercialization of Selenase ® (generic name: sodium Selenite Injection) for the treatment of selenium deficiency. biosyn Arzneimittel GmbH is a pharmaceutical and biotech company headquartered in Fellbach. biosyn specializes in trace elements, is a global market leader … Continue reading
In December 2022, Nang Kuang has entered into a long-term exclusive licensing partnership with Orion Corporation（Orion）for the commercialization of Budesonide Inhalation Powder and Salbutamol Sulfate Inhalation Powder. Orion is a globally operating Finnish pharmaceutical company founded in 1917. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is a … Continue reading
In December 2023, Nang Kuang has entered into a long-term exclusive co-development and licensing partnership with Esteve Pharmaceutical（Esteve）for R&D and commercialization of patented products for pain management. Esteve Pharmaceutical is the top pharmaceutical company in Spain. Founded in 1929 and headquartered in Barcelona, Spain, Esteve’s business covers the entire spectrum of R&D and manufacture, including … Continue reading
BEIJING Oct. 25，2023—-Nang Kuang has entered into a long-term exclusive distributing partnership with Chanelle Pharma (Chanelle) for the commercialization of Vardenafil Orodispersible 10mg Tablets for the treatment of erectile dysfunction. Vardenafil 10 mg Orodispersible Tablets is indicated for the treatment of erectile dysfunction in adult men. Erectile dysfunction is the inability to achieve or maintain … Continue reading
